PitchSend

Minerva IPO Presentation Deck

Minerva ES Clinical Trial Results Minerva Single-Arm Study: Hysterectomy rate at 36-month follow-up 6.3% 7x Less 0.9% Minerva ES Minerva RCT Study: Patient satisfaction at 12-month follow up¹ Novasure Source: FDA approved efficacy rates - Instructions for Use ¹Patients were asked about their level of satisfaction with their endometrial ablation treatment at 12-month follow-up Patient satisfaction difference achieved statistical superiority when compared to control 79.5% Control 91.8% Minerva ES 21

View entire presentation